Humacyte (HUMA) Director Keith Jones Buys 10,000 Shares

What Happened
Keith Anthony Jones, a director of Humacyte, purchased 10,000 shares of Humacyte common stock on August 20, 2026 at $0.69 per share, for a total reported value of $6,930. The transaction is reported with code "P" (purchase) and is described as an open-market or private purchase.

Key Details

• Transaction date: 2026-08-20; Price: $0.69 per share; Shares acquired: 10,000; Total value: $6,930.
• Transaction code: P (purchase — open-market or private purchase).
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnotes/plan: Filing did not disclose a 10b5‑1 plan, tax-withholding, or other special footnotes.
• Filing timeliness: Reported on Form 4 filed 2026-08-21 (timely relative to the transaction).

Context
Purchases by directors are often noted by investors as potentially favorable signals, though filings do not state the insider’s motivation. This was a relatively small-dollar open-market purchase by a director ($6.9k), so investors should weigh it alongside other insider activity and company fundamentals.